CSE CALI  |  Last $0.08  |  Change 0.00 OTC FNNZF  |  Last $0.06  |  Change 0.00

Our royalty investment forms part of a whole capital solution for our investee companies. We provide capital investment for a percentage of future revenues or profits and currently have invested in the following three companies.

QVI logoThe Galley logo

To visit The Galley website: http://www.thegalleysr.com

QVI, Inc., operating as “The Galley”, is a cannabis infused product manufacturer located in Sonoma, California. The Galley is a fully licensed 8,300 square foot facility and built to the high standards of both the Food and Drug Administration and the California Dept. of Public Health. The Galley is focused on high demand areas of production: Edibles, Topicals, Tinctures, Chocolates, Hard Candies, Gummies, Beverages, Vapes, Pre-Rolls and Flower Packaging. Under the Royalty Agreement, FinCanna receives a corporate royalty of 20% of QVI’s revenues, paid in cash monthly. Additionally, FinCanna will receive an Annual Supplemental Payment, that when coupled with the royalty, will ensure FinCanna receives from QVI a minimum of 70% of QVI’s annual after-tax net income, paid in cash every year. If QVI is sold, then FinCanna will receive 70% of the sales proceeds.

CTI logoCoachella Manufacturing logo

To visit the Coachella Manufacturing website: https://www.coachellamanufacturing.com/

Cultivation Technologies Inc. (“CTI”) operating as “Coachella Manufacturing”, is a multi-award winning extraction and manufacturing enterprise located in Palm Desert, California that provides high quality Butane Hash Oil (BHO) concentrates as well as higher velocity and higher volume ethanol-based and propane-based products for white label manufacturing, toll processing and packaging to hand-selected brands and cultivators in CA. Under the Royalty Agreement (fully funded), FinCanna earns a perpetual royalty of 10% of CTI’s revenues, of which 5% is paid in cash and 5% deferred until certain triggering events. FinCanna also earns an additional 10% royalty paid in cash monthly on all revenues from new production equipment to be installed in Q1 2021 until certain milestones are met. Additionally, FinCanna will be entitled to 25% to 50% of the sale proceeds of any change of control.

To visit the ezGreen Compliance website: https://www.ezgreencompliance.com/

ezGreen Compliance offers a state-of-the-art enterprise compliance and point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. The ezGreen software is the only HIPAA (Health Insurance Portability and Accountability Act) certified point-of-sale software in the market. In August 2020, FinCanna acquired from its former royalty portfolio company 100% of the assets and economic interests of ezGreen and is currently focused on growing its business in California and certain other states.

Subscribe for Updates